Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer
- PMID: 27332727
- DOI: 10.1016/j.immuni.2016.06.010
Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer
Abstract
Engineering T cells with chimeric antigen receptors (CARs) has demonstrated remarkable success in eradicating hematological malignancies. In this issue of Immunity, June and colleagues demonstrate the broad antitumor efficacy of a newly-designed CAR targeting the O-linked hypoglycosylated epitopes Tn and sialyl-Tn on cancer-associated MUC-1.
Copyright © 2016 Elsevier Inc. All rights reserved.
Comment on
-
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.Immunity. 2016 Jun 21;44(6):1444-54. doi: 10.1016/j.immuni.2016.05.014. Immunity. 2016. PMID: 27332733 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous